Variant report
Variant | esv3405581 |
---|---|
Chromosome Location | chr3:109652851-109653387 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529649362 | chr3:109652912-109652913 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs142422617 | chr3:109652918-109652919 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146432207 | chr3:109652921-109652922 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs642142 | chr3:109652923-109652924 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs139010584 | chr3:109652927-109652928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534814646 | chr3:109652971-109652972 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142967189 | chr3:109653006-109653007 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73851048 | chr3:109653024-109653025 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12635802 | chr3:109653115-109653116 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs556309359 | chr3:109653136-109653137 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs79647030 | chr3:109653181-109653182 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs369926976 | chr3:109653186-109653187 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs2700237 | chr3:109653287-109653288 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs150908529 | chr3:109653305-109653306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114001735 | chr3:109653317-109653318 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs13090723 | chr3:109653365-109653366 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73217683 | chr3:109653368-109653369 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs13090733 | chr3:109653375-109653376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Developmental delay | 22180640 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:109647000-109656000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr3:109651400-109654800 | Weak transcription | A549 | lung |
3 | chr3:109652800-109653800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr3:109653200-109653800 | Enhancers | Brain Germinal Matrix | brain |